Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomokazu Ohishi

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|January 6, 2016
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesTomokazu Ohishi, Fumitaka Koga, Toshiro Migita
Critical Reviews in Food Science and Nutrition|March 15, 2022
Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curryTomokazu Ohishi, Sumio Hayakawa, Noriyuki Miyoshi
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Evaluation of tankyrase inhibition in whole cellsTomokazu Ohishi, Takashi Tsuruo, Hiroyuki Seimiya
Oncoscience|June 11, 2026
Adaptor proteins regulating tumor-associated macrophage polarization during cancer progressionKhandu Wadhonkar, Tomokazu Ohishi, Mirza S Baig
FEBS Letters|August 11, 2010
Tankyrase-1 assembly to large protein complexes blocks its telomeric functionKaori Hatsugai, Tomokazu Ohishi, Yoshikazu Sugimoto, et al.
Cancer Research|February 18, 2010
TRF1 mediates mitotic abnormalities induced by Aurora-A overexpressionTomokazu Ohishi, Toru Hirota, Takashi Tsuruo, et al.
Molecular and Cellular Biology|April 23, 2014
TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregationTomokazu Ohishi, Yukiko Muramatsu, Haruka Yoshida, et al.
The Journal of Antibiotics|June 24, 2021
The therapeutic potential of mitochondrial toxinsManabu Kawada, Masahide Amemiya, Junjiro Yoshida, et al.
Cancer Cell|January 18, 2005
Tankyrase 1 as a target for telomere-directed molecular cancer therapeuticsHiroyuki Seimiya, Yukiko Muramatsu, Tomokazu Ohishi, et al.
Anticancer Research|May 29, 2023
Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer CellsDaisuke Tatsuda, Junjiro Yoshida, Tomokazu Ohishi, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|January 6, 2016
Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic PerspectivesTomokazu Ohishi, Fumitaka Koga, Toshiro Migita
Critical Reviews in Food Science and Nutrition|March 15, 2022
Involvement of microRNA modifications in anticancer effects of major polyphenols from green tea, coffee, wine, and curryTomokazu Ohishi, Sumio Hayakawa, Noriyuki Miyoshi
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Evaluation of tankyrase inhibition in whole cellsTomokazu Ohishi, Takashi Tsuruo, Hiroyuki Seimiya
Oncoscience|June 11, 2026
Adaptor proteins regulating tumor-associated macrophage polarization during cancer progressionKhandu Wadhonkar, Tomokazu Ohishi, Mirza S Baig
FEBS Letters|August 11, 2010
Tankyrase-1 assembly to large protein complexes blocks its telomeric functionKaori Hatsugai, Tomokazu Ohishi, Yoshikazu Sugimoto, et al.
Cancer Research|February 18, 2010
TRF1 mediates mitotic abnormalities induced by Aurora-A overexpressionTomokazu Ohishi, Toru Hirota, Takashi Tsuruo, et al.
Molecular and Cellular Biology|April 23, 2014
TRF1 ensures the centromeric function of Aurora-B and proper chromosome segregationTomokazu Ohishi, Yukiko Muramatsu, Haruka Yoshida, et al.
The Journal of Antibiotics|June 24, 2021
The therapeutic potential of mitochondrial toxinsManabu Kawada, Masahide Amemiya, Junjiro Yoshida, et al.
Cancer Cell|January 18, 2005
Tankyrase 1 as a target for telomere-directed molecular cancer therapeuticsHiroyuki Seimiya, Yukiko Muramatsu, Tomokazu Ohishi, et al.
Anticancer Research|May 29, 2023
Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer CellsDaisuke Tatsuda, Junjiro Yoshida, Tomokazu Ohishi, et al.
Pageof 11